PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.50%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-25.93%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-23.20%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.73%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.73%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.67%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
105.66%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
32.76%
FCF growth 50-75% of MTDR's 47.92%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-83.97%
Negative 10Y revenue/share CAGR while MTDR stands at 633.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
12.11%
5Y revenue/share CAGR under 50% of MTDR's 98.14%. Michael Burry would suspect a significant competitive gap or product weakness.
-48.06%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-91.64%
Negative 10Y OCF/share CAGR while MTDR stands at 3.87%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-73.86%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-78.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-80.99%
Negative 10Y net income/share CAGR while MTDR is at 1336.68%. Joel Greenblatt sees a major red flag in long-term profit erosion.
116.90%
Below 50% of MTDR's 335.53%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-6.98%
Negative 3Y CAGR while MTDR is 6.97%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-69.39%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.92%
Negative 5Y equity/share growth while MTDR is at 20.34%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.12%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-92.29%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.79%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-78.68%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.14%
AR growth well above MTDR's 11.75%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
2.14%
Asset growth well under 50% of MTDR's 5.38%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.95%
75-90% of MTDR's 4.69%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
1.30%
Debt growth far above MTDR's 0.00%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-14.81%
We cut SG&A while MTDR invests at 5.14%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.